- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
HAUPPAUGE, N.Y., USA: Crosstex has entered into a definitive agreement with North American Science Associates (NAMSA) to acquire its Sterility Assurance Monitoring Products division. This division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Crosstex.
Gary Steinberg, president and CEO of Crosstex, said, “This acquisition not only allows us to expand our sterility assurance product offering, but also broadens our presence into the important industrial market segment. We are also excited to provide additional product solutions to these customers with Crosstex’s complete infection prevention product portfolio.”
John Hughes, vice president and general manager of Crosstex/SPSmedical in Rochester, N.Y., stated, “The addition of NAMSA’s Sterility Assurance Products Division expands our market position in the biological and chemical integrator market while strengthening our manufacturing capabilities through greater vertical integration.”
Hughes went on to say, “We have retained the sales, marketing and customer care team, which will allow for a seamless transition and provide our new customers with the same level of service and support they have been accustomed to receiving.”
Subject to customary closing conditions, the transaction is expected to close in the third quarter of fiscal year 2016 for Crosstex.
(Source: Crosstex)
Fri. 3 May 2024
1:00 PM EST (New York)
Osseointegration in extrēmus: Complex maxillofacial reconstruction & rehabilitation praeteritum, praesens et futurum
Tue. 7 May 2024
8:00 PM EST (New York)
You got this! Diagnosis and management of common oral lesions
Thu. 9 May 2024
8:00 PM EST (New York)
Empowering your restorative practice: A comprehensive guide to clear aligner integration and success
Mon. 13 May 2024
9:00 AM EST (New York)
CREATING MORE PRACTICE TIME THROUGH EFFICIENCY: IMPROVED ACCURACY AND DELEGATION
Mon. 13 May 2024
1:00 PM EST (New York)
Súčasné trendy v parodontológii
Wed. 15 May 2024
10:00 AM EST (New York)
Der endodontische Notfall
Wed. 22 May 2024
12:00 PM EST (New York)
To post a reply please login or register